Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies
Juan C. Almagro, Gabriela Mellado‐Sánchez, Martha Pedraza‐Escalona, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9763-9763
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Therapeutics for COVID-19
Sima S. Toussi, Jennifer Hammond, Brian S. Gerstenberger, et al.
Nature Microbiology (2023) Vol. 8, Iss. 5, pp. 771-786
Open Access | Times Cited: 66
Exploring the Protective Effect of Food Drugs against Viral Diseases: Interaction of Functional Food Ingredients and SARS-CoV-2, Influenza Virus, and HSV
Andrea Ricci, Giovanni N. Roviello
Life (2023) Vol. 13, Iss. 2, pp. 402-402
Open Access | Times Cited: 19
Importance, Applications and Features of Assays Measuring SARS-CoV-2 Neutralizing Antibodies
Pia Gattinger, Anna Ohradanova‐Repic, Rudolf Valenta
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5352-5352
Open Access | Times Cited: 19
SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity
Joshua Tobias, Peter Steinberger, Joy Wilkinson, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 795-795
Open Access | Times Cited: 5
A bivalent spike-targeting nanobody with anti-sarbecovirus activity
Iris C. Swart, Oliver J. Debski-Antoniak, Aneta Zegar, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Antibody drugs targeting SARS-CoV-2: Time for a rethink?
Likeng Liang, Bo Wang, Qing Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116900-116900
Open Access | Times Cited: 4
Delta-Omicron recombinant escapes therapeutic antibody neutralization
Ralf Duerr, Hao Zhou, Takuya Tada, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 106075-106075
Open Access | Times Cited: 11
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
Natalia E. Ketaren, Fred D. Mast, Peter C. Fridy, et al.
eLife (2024) Vol. 12
Open Access | Times Cited: 3
A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors
Desh Deepak Singh, Ihn Han, Eun Ha Choi, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 1, pp. 400-433
Open Access | Times Cited: 6
Broad Epitope Coverage of Therapeutic Multi-Antibody Combinations Targeting SARS-CoV-2 Boosts In Vivo Protection and Neutralization Potency to Corner an Immune-Evading Virus
Ilse Roodink, Maartje van Erp, Andra Li, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 642-642
Open Access | Times Cited: 1
Why Should Vaccines against Respiratory Diseases Go Mucosal? B Cell Epitope-Based Vaccines against SARS-CoV-2
Joshua Tobias, Peter Steinberger, Joy Wilkinson, et al.
(2024)
Open Access | Times Cited: 1
Designed miniproteins potently inhibit and protect against MERS-CoV
Robert J. Ragotte, M. Alejandra Tortorici, Nicholas Catanzaro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
In Vitro and In Vivo Characterization of a Broadly Neutralizing Anti-SARS-CoV-2 Antibody Isolated from a Semi-Immune Phage Display Library
Edith González‐González, Gregorio Carballo‐Uicab, Juana Salinas-Trujano, et al.
Antibodies (2022) Vol. 11, Iss. 3, pp. 57-57
Open Access | Times Cited: 6
Anti-SARS-CoV-2 monoclonal antibodies for the treatment of mild-to-moderate COVID-19 in multiple sclerosis: A retrospective cohort study
Harry Jin, Caroline K. Geiger, Nikki Jessop, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 79, pp. 104943-104943
Closed Access | Times Cited: 3
Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant
Hui Sun, Yizhen Wang, Xiuting Chen, et al.
Journal of Virology (2023) Vol. 97, Iss. 11
Open Access | Times Cited: 3
A systematic study on the binding affinity of SARS-CoV-2 spike protein to antibodies
Ke An, Xiaohong Zhu, Junfang Yan, et al.
AIMS Microbiology (2022) Vol. 8, Iss. 4, pp. 595-611
Open Access | Times Cited: 5
Efficacy, Pharmacokinetic and Toxicity Profiles of a Broadly SARS-CoV2 Neutralizing Antibody
Silvia Godínez-Palma, Edith González‐González, Frida Ramírez-Villedas, et al.
(2023)
Open Access | Times Cited: 2
The proteolytic airway environment associated with pneumonia acts as a barrier for treatment with anti-infective antibodies
Timothée Blin, Christelle Parent, G. Pichón, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 195, pp. 114163-114163
Closed Access | Times Cited: 2
A Spike Trimer Dimer–Inducing Nanobody with Anti–Sarbecovirus Activity
Iris C. Swart, Oliver J. Debski-Antoniak, Aneta Zegar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Human monoclonal antibody cloning and expression with overlap extension PCR and short DNA fragments
Zachary Ende, Margarita Mishina, Robert C. Kauffman, et al.
Journal of Immunological Methods (2024) Vol. 534, pp. 113768-113768
Closed Access
Synthesis and Structure-Activity relationship of covalent inhibitors of SARS-CoV-2 papain-like protease with antiviral potency
C. Rouch, Arnab K. Chatterjee, Connor McCarty, et al.
Bioorganic & Medicinal Chemistry Letters (2024), pp. 130034-130034
Open Access
A potential antibody repertoire diversification mechanism through tyrosine sulfation for biotherapeutics engineering and production
Xiaotian Zhong, Aaron M. D’Antona
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus Libraries™
Omar U. Guzmán-Bringas, Keyla Gómez-Castellano, Edith González‐González, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4609-4609
Open Access | Times Cited: 1
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
Natalia E. Ketaren, Fred D. Mast, Peter C. Fridy, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 1
The Promise and Peril of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibodies
Jennifer M Davis, Jonathan Z. Li
Clinical Infectious Diseases (2022) Vol. 76, Iss. 7, pp. 1257-1259
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top